Durable response to treatment of an atypical desmoplastic small round cell tumor with enfortumab-vedotin. [PDF]
J Cancer Res Clin OncolWang JS +8 more
europepmc +1 more source
CAR-based cell therapy: evaluation with bibliometrics and patent analysis. [PDF]
Hum Vaccin Immunother, 2021 Yuan Y +6 more
europepmc +1 more source
The mutagenic activity of razoxane (ICRF 159): An anticancer agent
, 1985 R Albanese, P A Watkins
core +1 more source
Prevention of Heart Failure Induced by Doxorubicin with Early Administration of Dexrazoxane (PHOENIX Study): dose response and time course of dexrazoxane-induced degradation of topoisomerase 2b. [PDF]
CardiooncologyChang HM, Hsu JY, Ahn C, Yeh ETH.
europepmc +1 more source
5-Hydroxytryptophan acts as a gap junction inhibitor to limit the spread of chemotherapy-induced cardiomyocyte injury and mitochondrial dysfunction. [PDF]
Aging (Albany NY)Sun W, Lu Q, Zhang Y, Xing D.
europepmc +1 more source
Chemical and biological studies of the antitumour pro-drug razoxane.
, 1991 K.B. Nolan, L.P. Ryan, S.A. Kilfeather
core +1 more source
Induced clustering of SHP2-depleted tumor cells in vascular islands restores sensitivity to MEK/ERK inhibition. [PDF]
J Clin InvestWang Y +12 more
europepmc +1 more source
Looking for answers: the current status of neoadjuvant treatment in localized soft tissue sarcomas. [PDF]
Cancer Chemother Pharmacol, 2016 Nathenson MJ, Sausville E.
europepmc +1 more source
Apelin/APJ: Another Player in the Cancer Biology Network. [PDF]
Int J Mol SciNaldi L, Peri A, Fibbi B.
europepmc +1 more source
Chelation for autism spectrum disorder (ASD). [PDF]
Cochrane Database Syst Rev, 2015 James S +3 more
europepmc +1 more source